Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial - Grundy, S M; Vega, G L; McGovern, M E; Tulloch, B R; Kendall, D M; Fitz-Patrick, D; Ganda, O P; Rosenson, R S; Buse, J B; Robertson, D D; Sheehan, J PDiabetes Multicenter Research Group (Arch Intern Med, 2002)